PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Apple downgraded, Rivian initiated: Wall Street’s top analyst calls Leap Therapeutics price target lowered to $3 from $15 at Piper Sandler PremiumThe FlyLeap Therapeutics reports Q3 EPS (44c), consensus (48c) Leap Therapeutics (LPTX) Q3 Earnings Cheat Sheet Leap Therapeutics completes enrollment in Part B of DeFianCe study PremiumThe FlyLeap Therapeutics reports Q1 EPS (51c), consensus (58c) LPTX Earnings this Week: How Will it Perform? Leap Therapeutics files to sell 14.18M shares of common stock for holders 
